Relationship of vitamin D status with lung function and exercise capacity in COPD

Respirology

Volumn 20, Issue 5, 2015, Pages 782-789

  Jung, Ji Ye ^a   Kim, Young Sam ^a   Kim, Se Kyu ^a   Kim, Ha Yan ^b   Oh, Yeon Mok ^c   Lee, Sang Min ^c   Seo, Joon Beom ^c   Lee, Sang Do ^c  

^a Yonsei University College of Medicine   (South Korea)

^b Yonsei University College of Medicine   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

chronic obstructive pulmonary disease; exacerbation; exercise; lung function; vitamin D

Indexed keywords

BRONCHODILATING AGENT; CALCIFEDIOL;

AGED; ARTICLE; CALCIFEDIOL BLOOD LEVEL; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL FEATURE; CLUSTER ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE EXACERBATION; EMPHYSEMA; EXERCISE; FORCED VITAL CAPACITY; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; NUTRITIONAL STATUS; PATIENT CODING; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY TRACT PARAMETERS; SOUTH KOREA; SOUTH KOREAN; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; WALKING; BLOOD; DEFICIENCY; EXERCISE TOLERANCE; FEMALE; LUNG EMPHYSEMA; LUNG FUNCTION TEST; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

AGED; CALCIFEDIOL; COHORT STUDIES; EXERCISE TOLERANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; QUALITY OF LIFE; REPUBLIC OF KOREA; RESPIRATORY FUNCTION TESTS; VITAMIN D DEFICIENCY;

EID: 84931576680     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/resp.12538     Document Type: Article

References (28)

1. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (revised 2011). [Accessed 9 Mar 2012.] Available from URL: http://www.goldcopd.org/uploads/users/files/GOLD-Report-2011-Feb21.pdf.
2. Choi HS,. Vitamin D status in Korea. Endocrinol. Metab. 2013; 28: 12-16.
3. Choi HS, Oh HJ, Choi H, Choi WH, Kim JG, Kim KM, Kim KJ, Rhee Y, Lim SK,. Vitamin D insufficiency in Korea-a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008. J. Clin. Endocrinol. Metab. 2011; 96: 643-651.
4. Persson LJ, Aanerud M, Hiemstra PS, Hardie JA, Bakke PS, Eagan TM,. Chronic obstructive pulmonary disease is associated with low levels of vitamin D. PLoS ONE 2012; 7: e38934.
5. Black PN, Scragg R,. Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest 2005; 128: 3792-3798.
6. Shaheen SO, Jameson KA, Robinson SM, Boucher BJ, Syddall HE, Sayer AA, Cooper C, Holloway JW, Dennison EM,. Relationship of vitamin D status to adult lung function and COPD. Thorax 2011; 66: 692-698.
7. Janssens W, Bouillon R, Claes B, Carremans C, Lehouck A, Buysschaert I, Coolen J, Mathieu C, Decramer M, Lambrechts D,. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax 2010; 65: 215-220.
8. Kunisaki KM, Niewoehner DE, Connett JE,. Vitamin D levels and risk of acute exacerbations of chronic obstructive pulmonary disease: a prospective cohort study. Am. J. Respir. Crit. Care Med. 2012; 185: 286-290.
9. Romme EA, Rutten EP, Smeenk FW, Spruit MA, Menheere PP, Wouters EF,. Vitamin D status is associated with bone mineral density and functional exercise capacity in patients with chronic obstructive pulmonary disease. Ann. Med. 2013; 45: 91-96.
10. Ringbaek T, Martinez G, Durakovic A, Thogersen J, Midjord AK, Jensen JE, Lange P,. Vitamin D status in patients with chronic obstructive pulmonary disease who participate in pulmonary rehabilitation. J. Cardiopulm. Rehabil. Prev. 2011; 31: 261-267.
11. Jackson AS, Shrikrishna D, Kelly JL, Kemp SV, Hart N, Moxham J, Polkey MI, Kemp P, Hopkinson NS, Vitamin D,. and skeletal muscle strength and endurance in COPD. Eur. Respir. J. 2013; 41: 309-316.
12. Bjerk SM, Edgington BD, Rector TS, Kunisaki KM,. Supplemental vitamin D and physical performance in COPD: a pilot randomized trial. Int. J. Chronic Obstructive Pulm. Dis. 2013; 8: 97-104.
13. Berg I, Hanson C, Sayles H, Romberger D, Nelson A, Meza J, Miller B, Wouters EF, Macnee W, Rutten EP, et-al. Vitamin D binding protein, lung function and structure in COPD. Respir. Med. 2013; 107: 1578-1588.
14. Lehouck A, Mathieu C, Carremans C, Baeke F, Verhaegen J, Van Eldere J, Decallonne B, Bouillon R, Decramer M, Janssens W,. High doses of vitamin D to reduce exacerbations in chronic obstructive pulmonary disease: a randomized trial. Ann. Intern. Med. 2012; 156: 105-114.
15. Puhan MA, Siebeling L, Frei A, Zoller M, Bischoff-Ferrari H, Ter Riet G,. No association of 25-hydroxyvitamin D with exacerbations in primary care patients with COPD. Chest 2014; 145: 37-43.
16. Quint JK, Donaldson GC, Wassef N, Hurst JR, Thomas M, Wedzicha JA,. 25-hydroxyvitamin D deficiency, exacerbation frequency and human rhinovirus exacerbations in chronic obstructive pulmonary disease. BMC Pulm. Med. 2012; 12: 28.
17. Hornikx M, Van Remoortel H, Lehouck A, Mathieu C, Maes K, Gayan-Ramirez G, Decramer M, Troosters T, Janssens W,. Vitamin D supplementation during rehabilitation in COPD: a secondary analysis of a randomized trial. Respir. Res. 2012; 13: 84.
18. Holmgaard DB, Mygind LH, Titlestad IL, Madsen H, Fruekilde PB, Pedersen SS, Pedersen C,. Serum vitamin D in patients with chronic obstructive lung disease does not correlate with mortality-results from a 10-year prospective cohort study. PLoS ONE 2013; 8: e53670.
19. Afzal S, Lange P, Bojesen SE, Freiberg JJ, Nordestgaard BG,. Plasma 25-hydroxyvitamin D, lung function and risk of chronic obstructive pulmonary disease. Thorax 2014; 69: 24-31.
20. Skaaby T, Husemoen LL, Thuesen BH, Pisinger C, Jorgensen T, Fenger RV, Linneberg A,. Vitamin D status and chronic obstructive pulmonary disease: a prospective general population study. PLoS ONE 2014; 9: e90654.
21. Holick MF,. Vitamin D status: measurement, interpretation, and clinical application. Ann. Epidemiol. 2009; 19: 73-78.
22. ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am. J. Respir. Crit. Care Med. 2002; 166: 111-117.
23. Lee YK, Oh YM, Lee JH, Kim EK, Lee JH, Kim N, Seo JB, Lee SD,. Quantitative assessment of emphysema, air trapping, and airway thickening on computed tomography. Lung 2008; 186: 157-165.
24. Zeger SL, Liang KY,. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42: 121-130.
25. Choi CJ, Seo M, Choi WS, Kim KS, Youn SA, Lindsey T, Choi YJ, Kim CM,. Relationship between serum 25-hydroxyvitamin D and lung function among Korean adults in Korea National Health and Nutrition Examination Survey (KNHANES), 2008-2010. J. Clin. Endocrinol. Metab. 2013; 98: 1703-1710.
26. Moberg M, Ringbaek T, Roberts NB, Vestbo J,. Association between vitamin D status and COPD phenotypes. Lung 2014; 192: 493-497.
27. Stockton KA, Mengersen K, Paratz JD, Kandiah D, Bennell KL,. Effect of vitamin D supplementation on muscle strength: a systematic review and meta-analysis. Osteoporos Int. 2011; 22: 859-871.
28. Dirks-Naylor AJ, Lennon-Edwards S,. The effects of vitamin D on skeletal muscle function and cellular signaling. J. Steroid Biochem. Mol. Biol. 2011; 125: 159-168.